QoL and Cognitive Function in Patients With Hypoparathyroidism
NCT04569604 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 64
Last updated 2021-12-23
Summary
Hypoparathyroidism (HypoPT) is a disease with inadequate production of parathyroid hormone (PTH) from the parathyroid glands leading to hypocalcemia. The most common form is postsurgical HypoPT due to neck surgery resulting in removed or damaged parathyroid glands.
HypoPT is a complex disease with a reduced Quality of life, mild cognitive impairment and in some patients have brain calcifications.
The aim of the present study is to investigate the cognitive function in patients with postsurgical and non-surgical (HypoPT) by neuropsychological assessments and magnetic resonance imaging (MRI).
The investigators will apply a contrast-enhanced MRI based method to HypoPT patients and age- and gender matched controls to examine whether capillary dysfunction can be detected, and whether symptom severity across patients correlates with the degree of capillary dysfunction in certain brain regions. To our knowledge there have been no previous studies on cognitive impairment and its origin in patients with HypoPT. The investigators hypothesize that the symptoms of HypoPT patients represent various degrees of capillary dysfunction, which interfere with their brain function.
Conditions
- Hypoparathyroidism
- Pseudo Hypoparathyroidism
Interventions
- DIAGNOSTIC_TEST
-
MRI scans
Contrast-enhanced, magnetic resonance imaging (MRI) based method to detect disturbances in microvascular flow patterns in the human brain
- DIAGNOSTIC_TEST
-
Neuro cognitive tests
Standard neuropsychological test battery consists of validated tests to assess cognitive domains including verbal and visual memory, attention, language, visuospatial and executive functioning.
- DIAGNOSTIC_TEST
-
Questionnaires on Quality of Life
SF36v2, WHO-5 well-being index, HPQ28, Symptom questionnaire, and a general questionnaire on background information, medication and diet.
- DIAGNOSTIC_TEST
-
Blood samples
Markers of calcium homeostasis, inflammatory markers and hematology.
- DIAGNOSTIC_TEST
-
24 hr urine samples
24 hr urine content of calcium, phosphate, magnesium, and creatinine.
Sponsors & Collaborators
-
University of Aarhus
lead OTHER
Principal Investigators
-
Tanja T Sikjær, MD, PhD · Department of Endocrinology and Internal Medicine, Aarhus University Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-10-01
- Primary Completion
- 2020-10-01
- Completion
- 2021-12-01
Countries
- Denmark
Study Locations
More Related Trials
-
Percent Change in Baseline Bone Mineral Density (BMD) After Parathyroidectomy in Patients With Primary Hyperparathyroidism
NCT03052075 ·Status: UNKNOWN
-
Osteoporosis and Knee Insufficiency Fracture
NCT02332681 ·Status: UNKNOWN
-
Serum Calcium to Phosphorous (Ca/P) Ratio in the Diagnosis of Ca-P Metabolism Disorders: a Multicentre Study
NCT03747029 ·Status: COMPLETED
-
Prognosis Association of Hypocalcemia on Moderate-severe TBI, COHORTE STUDY
NCT01236911 ·Status: UNKNOWN
-
The Relationship Between Ca Intake , Blood Level of Ca, PTH, TSH, Vitamin D, and Urine Ca, P and Cardiac Calcium Scoring
NCT02035033 ·Status: UNKNOWN
-
Treatment With PTH After Sternotomy in Cardiac Surgery Patients
NCT01466829 ·Status: COMPLETED ·Phase: PHASE3
-
Psychological Determinants of the Therapeutic Observance of Osteoporotic Patients
NCT04029870 ·Status: COMPLETED
-
Multicenter Registry Study of Chronic Hypoparathyroidism in Chinese Adults
NCT05214274 ·Status: COMPLETED
-
Bone Architectural Parameters in Postmenopausal Women Affected With Primary Hyperparathyroidism
NCT02539498 ·Status: COMPLETED ·Phase: NA
-
Familial Hypocalciuric Hypercalcemia: Clinical Aspects and Evolution
NCT04872894 ·Status: COMPLETED
-
Hyponatremia in the Elderly: Benefit From a Change in Drug Therapy?
NCT01212211 ·Status: COMPLETED ·Phase: NA
-
PATHophysiology of OSteoporosis: Role of Hidden Cortisol Excess and Its Predictors in Bone Fragility
NCT06324084 ·Status: RECRUITING
-
Calibr-Ì: Comparative Evaluation of Phantomless Calibration Methods to Quantify Bone Mineral Density for Opportunistic Analysis of CT Scans
NCT06454617 ·Status: RECRUITING
-
Awareness of Osteoporosis in Patients With Hyperthyroidism
NCT05760417 ·Status: UNKNOWN
-
Bone Metabolism and Parathyroid Hormone-related Protein (PTHrP) Lactation Study
NCT00430417 ·Status: COMPLETED
-
Hypoparathyroidism Natural History Study
NCT05793853 ·Status: RECRUITING
-
Hormone Dynamics and Bone Mineral Density in Anorexia Nervosa v. Hypothalamic Amenorrhea
NCT00556036 ·Status: COMPLETED
-
Circulating miRNA in Primary Hyperparathyroidism
NCT03931109 ·Status: COMPLETED
-
Bone Mineral Content and Bone Metabolism in Adolescents on Antipsychotic Therapy
NCT00399776 ·Status: COMPLETED
-
Radiological Biological Genetic and Micro-architectural Bone Determinants of Fractures in Men With Low Bone Mineral Density
NCT01250314 ·Status: COMPLETED ·Phase: NA
-
Volumetric Bone Mineral Density and it's Relationship With Osteoporotic Fractures in Parkinson's Disease
NCT03095690 ·Status: COMPLETED ·Phase: NA
-
Role of the Protein Osteoprotegerin in the Bone Health of Women With Congenital Adrenal Hyperplasia
NCT00694525 ·Status: UNKNOWN
-
High- Versus Low-calcium Water for Bone Health
NCT05772364 ·Status: COMPLETED ·Phase: NA
-
Bone Mineral Density in Children With Graves' Disease
NCT06375096 ·Status: NOT_YET_RECRUITING
-
Awareness of Osteoporosis in Patients With Hypothyroidism
NCT05760131 ·Status: UNKNOWN